User profiles for "author:E Pathan"

Erum Pathan

Professor, Quaid-e-Awam University of Engineering, Science, & Technology, Nawabshah
Verified email at quest.edu.pk
Cited by 99

Can fungi compete with marine sources for chitosan production?

V Ghormade, EK Pathan, MV Deshpande - International journal of …, 2017 - Elsevier
Abstract Chitosan, a β-1, 4-linked glucosamine polymer is formed by deacetylation of chitin.
It has a wide range of applications from agriculture to human health care products. Chitosan …

[HTML][HTML] Frequency and voltage control techniques through inverter-interfaced distributed energy resources in microgrids: A review

…, M Eskandari, M Mansouri, AV Savkin, E Pathan - Energies, 2022 - mdpi.com
Microgrids (MG) are small-scale electric grids with local voltage control and power
management systems to facilitate the high penetration and grid integration of renewable …

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway

…, D Hull, K McNamee, A Jawad, E Pathan… - Annals of the …, 2012 - ard.bmj.com
Objectives To establish if changes in Th1/Th17 cell populations previously reported in
experimental arthritis occur in patients with rheumatoid arthritis (RA) treated with anti-tumour …

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis

E Pathan, S Abraham, E Van Rossen… - Annals of the …, 2013 - ard.bmj.com
Objectives To evaluate the efficacy and safety of an oral phosphodiesterase 4 inhibitor,
apremilast, in treatment of ankylosing spondylitis (AS) by monitoring symptoms and signs in …

[HTML][HTML] Relationship between diet and ankylosing spondylitis: a systematic review

TV Macfarlane, HM Abbood, E Pathan… - European journal of …, 2018 - ncbi.nlm.nih.gov
The question of whether diet plays a role in the onset of ankylosing spondylitis (AS) or can
affect the course of the disease is an important one for many patients and healthcare …

Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment

S Gaitonde, E Pathan, A Sule, G Mittal… - Annals of the rheumatic …, 2002 - ard.bmj.com
Objective: To study the efficacy of isoniazid prophylaxis (INHP) in patients with systemic
lupus erythematosus (SLE) receiving long term glucocorticosteroid treatment. Patients and …

[PDF][PDF] Co‐occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK national register

GJ Macfarlane, MS Barnish, E Pathan… - Arthritis & …, 2017 - Wiley Online Library
Objective To estimate the proportion of patients with axial spondyloarthritis (SpA) in a UK
national biologics registry who met criteria for fibromyalgia (FM), and to delineate the …

Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS …

J Shim, GT Jones, EMI Pathan… - Annals of the rheumatic …, 2018 - ard.bmj.com
Objectives To quantify, among patients with axial spondyloarthritis (axSpA), the benefit on
work outcomes associated with commencing biologic therapy. Methods The British Society …

Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR …

…, O Rotariu, GT Jones, E Pathan… - Annals of the …, 2020 - ard.bmj.com
Objective To determine modifiable factors associated with poor quality of life (QoL) in
patients with axial spondyloarthritis (axSpA). Methods Analysis of data from the British …

[HTML][HTML] The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: protocol for a prospective cohort study of the long-term …

…, L Kay, A Keat, KT Meldrum, E Pathan… - BMC musculoskeletal …, 2015 - Springer
Background Axial spondyloarthropathy typically has its onset in early adulthood and can
impact significantly on quality of life. In the UK, biologic anti-tumour necrosis factor therapy is …